nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—systemic lupus erythematosus—Amitriptyline—migraine	0.189	0.401	CpDpCtD
Celecoxib—systemic lupus erythematosus—Gabapentin—migraine	0.122	0.258	CpDpCtD
Celecoxib—rheumatoid arthritis—Amitriptyline—migraine	0.0975	0.207	CpDpCtD
Celecoxib—rheumatoid arthritis—Gabapentin—migraine	0.0629	0.133	CpDpCtD
Celecoxib—CA5A—Topiramate—migraine	0.0431	0.113	CbGbCtD
Celecoxib—CA6—Topiramate—migraine	0.0431	0.113	CbGbCtD
Celecoxib—CA5B—Topiramate—migraine	0.0375	0.0987	CbGbCtD
Celecoxib—CA12—Topiramate—migraine	0.0322	0.0847	CbGbCtD
Celecoxib—CA9—Topiramate—migraine	0.0322	0.0847	CbGbCtD
Celecoxib—ORM1—Propranolol—migraine	0.0285	0.075	CbGbCtD
Celecoxib—CA4—Topiramate—migraine	0.0283	0.0745	CbGbCtD
Celecoxib—CA2—Topiramate—migraine	0.026	0.0685	CbGbCtD
Celecoxib—ORM1—Amitriptyline—migraine	0.0247	0.0649	CbGbCtD
Celecoxib—ABCC4—Verapamil—migraine	0.0222	0.0584	CbGbCtD
Celecoxib—ALB—Amitriptyline—migraine	0.0104	0.0273	CbGbCtD
Celecoxib—CA5B—cervicothoracic ganglion—migraine	0.00981	0.336	CbGeAlD
Celecoxib—CYP2D6—Timolol—migraine	0.00664	0.0174	CbGbCtD
Celecoxib—CYP2D6—Propranolol—migraine	0.00591	0.0156	CbGbCtD
Celecoxib—CYP2C9—Amitriptyline—migraine	0.00559	0.0147	CbGbCtD
Celecoxib—CYP2D6—Amitriptyline—migraine	0.00512	0.0135	CbGbCtD
Celecoxib—CYP2C9—Valproic Acid—migraine	0.0051	0.0134	CbGbCtD
Celecoxib—CYP2C9—Verapamil—migraine	0.00444	0.0117	CbGbCtD
Celecoxib—CYP2D6—Verapamil—migraine	0.00406	0.0107	CbGbCtD
Celecoxib—CYP3A4—Propranolol—migraine	0.00376	0.00989	CbGbCtD
Celecoxib—CYP3A4—Amitriptyline—migraine	0.00325	0.00855	CbGbCtD
Celecoxib—CYP3A4—Valproic Acid—migraine	0.00296	0.0078	CbGbCtD
Celecoxib—CYP3A4—Topiramate—migraine	0.00267	0.00703	CbGbCtD
Celecoxib—CYP3A4—Verapamil—migraine	0.00258	0.00679	CbGbCtD
Celecoxib—PDPK1—trigeminal ganglion—migraine	0.00132	0.0453	CbGeAlD
Celecoxib—MAPK14—blood vessel—migraine	0.00115	0.0392	CbGeAlD
Celecoxib—MAPK14—neck—migraine	0.00082	0.0281	CbGeAlD
Celecoxib—CA4—nerve—migraine	0.000685	0.0235	CbGeAlD
Celecoxib—PDPK1—head—migraine	0.000647	0.0222	CbGeAlD
Celecoxib—MAPK14—brainstem—migraine	0.000626	0.0214	CbGeAlD
Celecoxib—PDPK1—nervous system—migraine	0.000614	0.021	CbGeAlD
Celecoxib—PDPK1—central nervous system—migraine	0.000591	0.0202	CbGeAlD
Celecoxib—PDPK1—cerebellum—migraine	0.000577	0.0198	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—migraine	0.000511	0.0175	CbGeAlD
Celecoxib—MAPK14—CDO in myogenesis—MEF2D—migraine	0.000496	0.0344	CbGpPWpGaD
Celecoxib—PDPK1—brain—migraine	0.000469	0.0161	CbGeAlD
Celecoxib—MAPK14—p38 MAPK Signaling Pathway—MEF2D—migraine	0.000437	0.0303	CbGpPWpGaD
Celecoxib—CA6—head—migraine	0.000392	0.0134	CbGeAlD
Celecoxib—CA4—neck—migraine	0.000385	0.0132	CbGeAlD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.000364	0.0252	CbGpPWpGaD
Celecoxib—ALB—Scavenging of heme from plasma—LRP1—migraine	0.000356	0.0246	CbGpPWpGaD
Celecoxib—CA5B—cardiovascular system—migraine	0.000348	0.0119	CbGeAlD
Celecoxib—MAPK14—head—migraine	0.000346	0.0119	CbGeAlD
Celecoxib—PTGS2—blood vessel—migraine	0.000329	0.0113	CbGeAlD
Celecoxib—MAPK14—nervous system—migraine	0.000328	0.0112	CbGeAlD
Celecoxib—CA2—neck—migraine	0.000319	0.0109	CbGeAlD
Celecoxib—CA9—cerebellum—migraine	0.000317	0.0108	CbGeAlD
Celecoxib—MAPK14—central nervous system—migraine	0.000316	0.0108	CbGeAlD
Celecoxib—MAPK14—cerebellum—migraine	0.000309	0.0106	CbGeAlD
Celecoxib—MAPK14—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.000302	0.0209	CbGpPWpGaD
Celecoxib—MAPK14—Mitochondrial biogenesis—MEF2D—migraine	0.000302	0.0209	CbGpPWpGaD
Celecoxib—CA14—cerebellum—migraine	0.0003	0.0103	CbGeAlD
Celecoxib—PDPK1—Neuronal System—KCNK18—migraine	0.000297	0.0206	CbGpPWpGaD
Celecoxib—CA4—brainstem—migraine	0.000294	0.0101	CbGeAlD
Celecoxib—MAPK14—Activation of the AP-1 family of transcription factors—FOS—migraine	0.000287	0.0199	CbGpPWpGaD
Celecoxib—CA2—trigeminal ganglion—migraine	0.000276	0.00944	CbGeAlD
Celecoxib—MAPK14—IL4-mediated signaling events—LTA—migraine	0.00027	0.0187	CbGpPWpGaD
Celecoxib—CA12—head—migraine	0.000263	0.00899	CbGeAlD
Celecoxib—MAPK14—brain—migraine	0.000251	0.00859	CbGeAlD
Celecoxib—CA12—nervous system—migraine	0.000249	0.00853	CbGeAlD
Celecoxib—CA14—brain—migraine	0.000244	0.00836	CbGeAlD
Celecoxib—CA2—brainstem—migraine	0.000244	0.00835	CbGeAlD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000241	0.0167	CbGpPWpGaD
Celecoxib—CA4—cardiovascular system—migraine	0.00024	0.00822	CbGeAlD
Celecoxib—CA12—central nervous system—migraine	0.00024	0.00821	CbGeAlD
Celecoxib—CA5B—head—migraine	0.000236	0.00807	CbGeAlD
Celecoxib—MAPK14—Monoamine Transport—SLC6A4—migraine	0.00023	0.016	CbGpPWpGaD
Celecoxib—PDPK1—TGF-beta receptor signaling—TGFBR2—migraine	0.000227	0.0157	CbGpPWpGaD
Celecoxib—CA5B—nervous system—migraine	0.000223	0.00765	CbGeAlD
Celecoxib—CA5B—central nervous system—migraine	0.000215	0.00736	CbGeAlD
Celecoxib—PTGS2—trigeminal ganglion—migraine	0.000204	0.00697	CbGeAlD
Celecoxib—CA2—cardiovascular system—migraine	0.000199	0.00682	CbGeAlD
Celecoxib—ORM1—nervous system—migraine	0.000198	0.00677	CbGeAlD
Celecoxib—MAPK14—FSH signaling pathway—BDNF—migraine	0.000192	0.0133	CbGpPWpGaD
Celecoxib—CA12—brain—migraine	0.00019	0.00652	CbGeAlD
Celecoxib—ORM1—central nervous system—migraine	0.00019	0.00651	CbGeAlD
Celecoxib—PDPK1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000189	0.0131	CbGpPWpGaD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.000189	0.0131	CbGpPWpGaD
Celecoxib—ABCC4—head—migraine	0.000177	0.00606	CbGeAlD
Celecoxib—CA5B—brain—migraine	0.000171	0.00585	CbGeAlD
Celecoxib—CYP2C9—cardiovascular system—migraine	0.000168	0.00577	CbGeAlD
Celecoxib—ABCC4—nervous system—migraine	0.000168	0.00574	CbGeAlD
Celecoxib—MAPK14—Estrogen signaling pathway—ESR1—migraine	0.000163	0.0113	CbGpPWpGaD
Celecoxib—CA4—head—migraine	0.000163	0.00557	CbGeAlD
Celecoxib—ABCC4—central nervous system—migraine	0.000161	0.00553	CbGeAlD
Celecoxib—ABCC4—Fluoropyrimidine Activity—MTHFR—migraine	0.000157	0.0109	CbGpPWpGaD
Celecoxib—CYP2D6—brainstem—migraine	0.000155	0.0053	CbGeAlD
Celecoxib—CA4—nervous system—migraine	0.000154	0.00528	CbGeAlD
Celecoxib—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.000151	0.0104	CbGpPWpGaD
Celecoxib—CA4—central nervous system—migraine	0.000148	0.00508	CbGeAlD
Celecoxib—MAPK14—Estrogen signaling pathway—FOS—migraine	0.000147	0.0102	CbGpPWpGaD
Celecoxib—PTGS2—cardiovascular system—migraine	0.000147	0.00503	CbGeAlD
Celecoxib—PDPK1—Neuronal System—CACNA1A—migraine	0.000145	0.0101	CbGpPWpGaD
Celecoxib—CA4—cerebellum—migraine	0.000145	0.00497	CbGeAlD
Celecoxib—PDPK1—FGF signaling pathway—FOS—migraine	0.000143	0.00991	CbGpPWpGaD
Celecoxib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000142	0.00983	CbGpPWpGaD
Celecoxib—MAPK14—Physiological and Pathological Hypertrophy  of the Heart—FOS—migraine	0.000138	0.00954	CbGpPWpGaD
Celecoxib—MAPK14—Organelle biogenesis and maintenance—MEF2D—migraine	0.000137	0.00949	CbGpPWpGaD
Celecoxib—CA2—head—migraine	0.000135	0.00462	CbGeAlD
Celecoxib—MAPK14—S1P2 pathway—FOS—migraine	0.000133	0.00924	CbGpPWpGaD
Celecoxib—ALB—brain—migraine	0.000132	0.00453	CbGeAlD
Celecoxib—MAPK14—Endothelins—EDNRA—migraine	0.00013	0.00903	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by ERBB4—PGR—migraine	0.00013	0.009	CbGpPWpGaD
Celecoxib—ABCC4—brain—migraine	0.000128	0.00439	CbGeAlD
Celecoxib—CA2—nervous system—migraine	0.000128	0.00438	CbGeAlD
Celecoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000126	0.00871	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000125	0.00868	CbGpPWpGaD
Celecoxib—CA2—central nervous system—migraine	0.000123	0.00421	CbGeAlD
Celecoxib—PDPK1—TSH signaling pathway—FOS—migraine	0.000122	0.00844	CbGpPWpGaD
Celecoxib—PDPK1—BCR signaling pathway—FOS—migraine	0.00012	0.00834	CbGpPWpGaD
Celecoxib—CA2—cerebellum—migraine	0.00012	0.00412	CbGeAlD
Celecoxib—MAPK14—MAPK targets/ Nuclear events mediated by MAP kinases—FOS—migraine	0.000119	0.00824	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress—FOS—migraine	0.000119	0.00824	CbGpPWpGaD
Celecoxib—CA4—brain—migraine	0.000118	0.00404	CbGeAlD
Celecoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000117	0.00809	CbGpPWpGaD
Celecoxib—MAPK14—Trk receptor signaling mediated by the MAPK pathway—FOS—migraine	0.000108	0.00746	CbGpPWpGaD
Celecoxib—CA9—HIF-1-alpha transcription factor network—FOS—migraine	0.000105	0.00727	CbGpPWpGaD
Celecoxib—PTGS2—head—migraine	9.95e-05	0.00341	CbGeAlD
Celecoxib—CA2—brain—migraine	9.77e-05	0.00335	CbGeAlD
Celecoxib—PDPK1—BDNF signaling pathway—BDNF—migraine	9.66e-05	0.00669	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—FOS—migraine	9.51e-05	0.00659	CbGpPWpGaD
Celecoxib—PTGS2—nervous system—migraine	9.44e-05	0.00323	CbGeAlD
Celecoxib—PTGS2—central nervous system—migraine	9.08e-05	0.00311	CbGeAlD
Celecoxib—PTGS2—cerebellum—migraine	8.88e-05	0.00304	CbGeAlD
Celecoxib—CYP2D6—head—migraine	8.56e-05	0.00293	CbGeAlD
Celecoxib—ABCC4—Transmembrane transport of small molecules—TRPM8—migraine	8.46e-05	0.00586	CbGpPWpGaD
Celecoxib—PDPK1—ErbB1 downstream signaling—FOS—migraine	8.41e-05	0.00582	CbGpPWpGaD
Celecoxib—MAPK14—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	8.31e-05	0.00576	CbGpPWpGaD
Celecoxib—MAPK14—IL6-mediated signaling events—FOS—migraine	8.31e-05	0.00576	CbGpPWpGaD
Celecoxib—CYP3A4—nervous system—migraine	8.25e-05	0.00282	CbGeAlD
Celecoxib—CYP2D6—nervous system—migraine	8.11e-05	0.00278	CbGeAlD
Celecoxib—CYP3A4—central nervous system—migraine	7.94e-05	0.00272	CbGeAlD
Celecoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	7.81e-05	0.00541	CbGpPWpGaD
Celecoxib—CYP2D6—central nervous system—migraine	7.81e-05	0.00268	CbGeAlD
Celecoxib—ABCC4—NRF2 pathway—SLC6A4—migraine	7.81e-05	0.00541	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—ESR1—migraine	7.69e-05	0.00532	CbGpPWpGaD
Celecoxib—CYP2D6—cerebellum—migraine	7.64e-05	0.00262	CbGeAlD
Celecoxib—PDPK1—Cardiac Hypertrophic Response—TNF—migraine	7.58e-05	0.00525	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—RAMP1—migraine	7.52e-05	0.00521	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CALCRL—migraine	7.52e-05	0.00521	CbGpPWpGaD
Celecoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	7.46e-05	0.00517	CbGpPWpGaD
Celecoxib—MAPK14—IL2-mediated signaling events—FOS—migraine	7.44e-05	0.00515	CbGpPWpGaD
Celecoxib—MAPK14—FGF signaling pathway—FOS—migraine	7.44e-05	0.00515	CbGpPWpGaD
Celecoxib—MAPK14—IL-4 Signaling Pathway—FOS—migraine	7.44e-05	0.00515	CbGpPWpGaD
Celecoxib—Urinary tract infection—Topiramate—migraine	7.42e-05	0.000707	CcSEcCtD
Celecoxib—Nervousness—Timolol—migraine	7.4e-05	0.000705	CcSEcCtD
Celecoxib—Hypertension—Valproic Acid—migraine	7.39e-05	0.000704	CcSEcCtD
Celecoxib—Immune system disorder—Gabapentin—migraine	7.36e-05	0.000701	CcSEcCtD
Celecoxib—Mediastinal disorder—Gabapentin—migraine	7.34e-05	0.0007	CcSEcCtD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—FOS—migraine	7.33e-05	0.00508	CbGpPWpGaD
Celecoxib—Diarrhoea—Propranolol—migraine	7.33e-05	0.000698	CcSEcCtD
Celecoxib—Chest pain—Valproic Acid—migraine	7.29e-05	0.000694	CcSEcCtD
Celecoxib—Myalgia—Valproic Acid—migraine	7.29e-05	0.000694	CcSEcCtD
Celecoxib—Arthralgia—Valproic Acid—migraine	7.29e-05	0.000694	CcSEcCtD
Celecoxib—Haematuria—Topiramate—migraine	7.28e-05	0.000694	CcSEcCtD
Celecoxib—Anxiety—Valproic Acid—migraine	7.26e-05	0.000692	CcSEcCtD
Celecoxib—Hypersensitivity—Verapamil—migraine	7.26e-05	0.000692	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	7.24e-05	0.00069	CcSEcCtD
Celecoxib—MAPK14—MAP kinase activation in TLR cascade—FOS—migraine	7.22e-05	0.005	CbGpPWpGaD
Celecoxib—PTGS2—brain—migraine	7.21e-05	0.00247	CbGeAlD
Celecoxib—Epistaxis—Topiramate—migraine	7.2e-05	0.000687	CcSEcCtD
Celecoxib—Alopecia—Gabapentin—migraine	7.2e-05	0.000686	CcSEcCtD
Celecoxib—Vision blurred—Timolol—migraine	7.18e-05	0.000684	CcSEcCtD
Celecoxib—Sinusitis—Topiramate—migraine	7.17e-05	0.000683	CcSEcCtD
Celecoxib—Mental disorder—Gabapentin—migraine	7.14e-05	0.00068	CcSEcCtD
Celecoxib—Agranulocytosis—Topiramate—migraine	7.13e-05	0.000679	CcSEcCtD
Celecoxib—Dry mouth—Valproic Acid—migraine	7.13e-05	0.000679	CcSEcCtD
Celecoxib—Dizziness—Propranolol—migraine	7.08e-05	0.000675	CcSEcCtD
Celecoxib—Asthenia—Verapamil—migraine	7.07e-05	0.000674	CcSEcCtD
Celecoxib—Confusional state—Valproic Acid—migraine	7.04e-05	0.000671	CcSEcCtD
Celecoxib—Flatulence—Gabapentin—migraine	6.99e-05	0.000666	CcSEcCtD
Celecoxib—Oedema—Valproic Acid—migraine	6.98e-05	0.000666	CcSEcCtD
Celecoxib—Anaphylactic shock—Valproic Acid—migraine	6.98e-05	0.000666	CcSEcCtD
Celecoxib—Pruritus—Verapamil—migraine	6.97e-05	0.000664	CcSEcCtD
Celecoxib—Tension—Gabapentin—migraine	6.96e-05	0.000663	CcSEcCtD
Celecoxib—Angioedema—Timolol—migraine	6.96e-05	0.000663	CcSEcCtD
Celecoxib—Dysgeusia—Gabapentin—migraine	6.95e-05	0.000662	CcSEcCtD
Celecoxib—Infection—Valproic Acid—migraine	6.94e-05	0.000661	CcSEcCtD
Celecoxib—PDPK1—Signaling by ERBB4—ESR1—migraine	6.94e-05	0.00481	CbGpPWpGaD
Celecoxib—MAPK14—Kit receptor signaling pathway—FOS—migraine	6.93e-05	0.0048	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—FOS—migraine	6.93e-05	0.0048	CbGpPWpGaD
Celecoxib—Haemoglobin—Topiramate—migraine	6.89e-05	0.000657	CcSEcCtD
Celecoxib—Nervousness—Gabapentin—migraine	6.89e-05	0.000657	CcSEcCtD
Celecoxib—Rhinitis—Topiramate—migraine	6.87e-05	0.000655	CcSEcCtD
Celecoxib—Back pain—Gabapentin—migraine	6.86e-05	0.000654	CcSEcCtD
Celecoxib—Hepatitis—Topiramate—migraine	6.86e-05	0.000653	CcSEcCtD
Celecoxib—Haemorrhage—Topiramate—migraine	6.86e-05	0.000653	CcSEcCtD
Celecoxib—Nervous system disorder—Valproic Acid—migraine	6.85e-05	0.000653	CcSEcCtD
Celecoxib—Vertigo—Timolol—migraine	6.84e-05	0.000652	CcSEcCtD
Celecoxib—Thrombocytopenia—Valproic Acid—migraine	6.84e-05	0.000652	CcSEcCtD
Celecoxib—MAPK14—IL12-mediated signaling events—FOS—migraine	6.84e-05	0.00473	CbGpPWpGaD
Celecoxib—Syncope—Timolol—migraine	6.83e-05	0.000651	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—RAMP1—migraine	6.83e-05	0.00473	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CALCRL—migraine	6.83e-05	0.00473	CbGpPWpGaD
Celecoxib—Hallucination—Topiramate—migraine	6.82e-05	0.00065	CcSEcCtD
Celecoxib—Hypoaesthesia—Topiramate—migraine	6.82e-05	0.00065	CcSEcCtD
Celecoxib—Muscle spasms—Gabapentin—migraine	6.82e-05	0.00065	CcSEcCtD
Celecoxib—Tachycardia—Valproic Acid—migraine	6.82e-05	0.00065	CcSEcCtD
Celecoxib—Vomiting—Propranolol—migraine	6.81e-05	0.000649	CcSEcCtD
Celecoxib—Pharyngitis—Topiramate—migraine	6.8e-05	0.000648	CcSEcCtD
Celecoxib—Skin disorder—Valproic Acid—migraine	6.78e-05	0.000646	CcSEcCtD
Celecoxib—Urinary tract disorder—Topiramate—migraine	6.77e-05	0.000645	CcSEcCtD
Celecoxib—Oedema peripheral—Topiramate—migraine	6.75e-05	0.000644	CcSEcCtD
Celecoxib—Hyperhidrosis—Valproic Acid—migraine	6.75e-05	0.000643	CcSEcCtD
Celecoxib—Rash—Propranolol—migraine	6.75e-05	0.000643	CcSEcCtD
Celecoxib—Dermatitis—Propranolol—migraine	6.75e-05	0.000643	CcSEcCtD
Celecoxib—Diarrhoea—Verapamil—migraine	6.74e-05	0.000642	CcSEcCtD
Celecoxib—Connective tissue disorder—Topiramate—migraine	6.74e-05	0.000642	CcSEcCtD
Celecoxib—Palpitations—Timolol—migraine	6.73e-05	0.000642	CcSEcCtD
Celecoxib—Urethral disorder—Topiramate—migraine	6.72e-05	0.00064	CcSEcCtD
Celecoxib—Loss of consciousness—Timolol—migraine	6.7e-05	0.000638	CcSEcCtD
Celecoxib—Vision blurred—Gabapentin—migraine	6.69e-05	0.000637	CcSEcCtD
Celecoxib—Anorexia—Valproic Acid—migraine	6.66e-05	0.000634	CcSEcCtD
Celecoxib—Cough—Timolol—migraine	6.65e-05	0.000634	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—SCN1A—migraine	6.61e-05	0.00458	CbGpPWpGaD
Celecoxib—Hypertension—Timolol—migraine	6.58e-05	0.000627	CcSEcCtD
Celecoxib—MAPK14—Endothelins—FOS—migraine	6.57e-05	0.00455	CbGpPWpGaD
Celecoxib—Anaemia—Gabapentin—migraine	6.56e-05	0.000625	CcSEcCtD
Celecoxib—PDPK1—BDNF signaling pathway—FOS—migraine	6.53e-05	0.00452	CbGpPWpGaD
Celecoxib—Dizziness—Verapamil—migraine	6.51e-05	0.000621	CcSEcCtD
Celecoxib—Arthralgia—Timolol—migraine	6.49e-05	0.000618	CcSEcCtD
Celecoxib—Chest pain—Timolol—migraine	6.49e-05	0.000618	CcSEcCtD
Celecoxib—Myalgia—Timolol—migraine	6.49e-05	0.000618	CcSEcCtD
Celecoxib—Erythema multiforme—Topiramate—migraine	6.48e-05	0.000618	CcSEcCtD
Celecoxib—Angioedema—Gabapentin—migraine	6.48e-05	0.000618	CcSEcCtD
Celecoxib—Anxiety—Timolol—migraine	6.46e-05	0.000616	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	6.44e-05	0.000614	CcSEcCtD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—FOS—migraine	6.41e-05	0.00444	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ATP1A3—migraine	6.41e-05	0.00444	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ATP1A2—migraine	6.41e-05	0.00444	CbGpPWpGaD
Celecoxib—Eye disorder—Topiramate—migraine	6.41e-05	0.000611	CcSEcCtD
Celecoxib—Tinnitus—Topiramate—migraine	6.39e-05	0.000609	CcSEcCtD
Celecoxib—Vertigo—Gabapentin—migraine	6.37e-05	0.000607	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Valproic Acid—migraine	6.36e-05	0.000606	CcSEcCtD
Celecoxib—Cardiac disorder—Topiramate—migraine	6.36e-05	0.000606	CcSEcCtD
Celecoxib—Flushing—Topiramate—migraine	6.36e-05	0.000606	CcSEcCtD
Celecoxib—Syncope—Gabapentin—migraine	6.36e-05	0.000606	CcSEcCtD
Celecoxib—Nausea—Propranolol—migraine	6.36e-05	0.000606	CcSEcCtD
Celecoxib—Leukopenia—Gabapentin—migraine	6.35e-05	0.000605	CcSEcCtD
Celecoxib—MAPK14—Leptin signaling pathway—ESR1—migraine	6.34e-05	0.00439	CbGpPWpGaD
Celecoxib—Dry mouth—Timolol—migraine	6.34e-05	0.000604	CcSEcCtD
Celecoxib—MAPK14—TSH signaling pathway—FOS—migraine	6.33e-05	0.00439	CbGpPWpGaD
Celecoxib—Insomnia—Valproic Acid—migraine	6.32e-05	0.000602	CcSEcCtD
Celecoxib—Paraesthesia—Valproic Acid—migraine	6.27e-05	0.000598	CcSEcCtD
Celecoxib—Palpitations—Gabapentin—migraine	6.27e-05	0.000597	CcSEcCtD
Celecoxib—Confusional state—Timolol—migraine	6.27e-05	0.000597	CcSEcCtD
Celecoxib—Vomiting—Verapamil—migraine	6.26e-05	0.000597	CcSEcCtD
Celecoxib—MAPK14—BCR signaling pathway—FOS—migraine	6.26e-05	0.00433	CbGpPWpGaD
Celecoxib—Loss of consciousness—Gabapentin—migraine	6.24e-05	0.000594	CcSEcCtD
Celecoxib—Dyspnoea—Valproic Acid—migraine	6.23e-05	0.000593	CcSEcCtD
Celecoxib—Angiopathy—Topiramate—migraine	6.22e-05	0.000593	CcSEcCtD
Celecoxib—Oedema—Timolol—migraine	6.22e-05	0.000593	CcSEcCtD
Celecoxib—Anaphylactic shock—Timolol—migraine	6.22e-05	0.000593	CcSEcCtD
Celecoxib—Rash—Verapamil—migraine	6.21e-05	0.000592	CcSEcCtD
Celecoxib—Somnolence—Valproic Acid—migraine	6.21e-05	0.000592	CcSEcCtD
Celecoxib—Dermatitis—Verapamil—migraine	6.21e-05	0.000591	CcSEcCtD
Celecoxib—CYP2D6—brain—migraine	6.2e-05	0.00212	CbGeAlD
Celecoxib—Immune system disorder—Topiramate—migraine	6.19e-05	0.00059	CcSEcCtD
Celecoxib—Cough—Gabapentin—migraine	6.19e-05	0.00059	CcSEcCtD
Celecoxib—Mediastinal disorder—Topiramate—migraine	6.18e-05	0.000589	CcSEcCtD
Celecoxib—Infection—Timolol—migraine	6.18e-05	0.000589	CcSEcCtD
Celecoxib—Headache—Verapamil—migraine	6.17e-05	0.000588	CcSEcCtD
Celecoxib—Dyspepsia—Valproic Acid—migraine	6.15e-05	0.000586	CcSEcCtD
Celecoxib—Hypertension—Gabapentin—migraine	6.12e-05	0.000584	CcSEcCtD
Celecoxib—Shock—Timolol—migraine	6.12e-05	0.000583	CcSEcCtD
Celecoxib—Nervous system disorder—Timolol—migraine	6.1e-05	0.000581	CcSEcCtD
Celecoxib—MAPK14—Monoamine Transport—TNF—migraine	6.08e-05	0.00421	CbGpPWpGaD
Celecoxib—Decreased appetite—Valproic Acid—migraine	6.07e-05	0.000579	CcSEcCtD
Celecoxib—Alopecia—Topiramate—migraine	6.06e-05	0.000577	CcSEcCtD
Celecoxib—Chest pain—Gabapentin—migraine	6.04e-05	0.000576	CcSEcCtD
Celecoxib—Arthralgia—Gabapentin—migraine	6.04e-05	0.000576	CcSEcCtD
Celecoxib—Myalgia—Gabapentin—migraine	6.04e-05	0.000576	CcSEcCtD
Celecoxib—Skin disorder—Timolol—migraine	6.04e-05	0.000576	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Valproic Acid—migraine	6.03e-05	0.000575	CcSEcCtD
Celecoxib—Fatigue—Valproic Acid—migraine	6.02e-05	0.000574	CcSEcCtD
Celecoxib—Anxiety—Gabapentin—migraine	6.02e-05	0.000574	CcSEcCtD
Celecoxib—Hyperhidrosis—Timolol—migraine	6.01e-05	0.000573	CcSEcCtD
Celecoxib—Mental disorder—Topiramate—migraine	6.01e-05	0.000572	CcSEcCtD
Celecoxib—PDPK1—Insulin Signaling—FOS—migraine	6e-05	0.00416	CbGpPWpGaD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	6e-05	0.000572	CcSEcCtD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	5.99e-05	0.00415	CbGpPWpGaD
Celecoxib—Constipation—Valproic Acid—migraine	5.97e-05	0.000569	CcSEcCtD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—FOS—migraine	5.94e-05	0.00412	CbGpPWpGaD
Celecoxib—Anorexia—Timolol—migraine	5.93e-05	0.000565	CcSEcCtD
Celecoxib—Dry mouth—Gabapentin—migraine	5.91e-05	0.000563	CcSEcCtD
Celecoxib—ABCC4—NRF2 pathway—TGFBR2—migraine	5.89e-05	0.00408	CbGpPWpGaD
Celecoxib—PTGS2—Overview of nanoparticle effects—TNF—migraine	5.89e-05	0.00408	CbGpPWpGaD
Celecoxib—Flatulence—Topiramate—migraine	5.88e-05	0.00056	CcSEcCtD
Celecoxib—Tension—Topiramate—migraine	5.86e-05	0.000558	CcSEcCtD
Celecoxib—Nausea—Verapamil—migraine	5.85e-05	0.000558	CcSEcCtD
Celecoxib—Dysgeusia—Topiramate—migraine	5.84e-05	0.000557	CcSEcCtD
Celecoxib—Confusional state—Gabapentin—migraine	5.84e-05	0.000556	CcSEcCtD
Celecoxib—CA14—Metabolism—CACNA1A—migraine	5.8e-05	0.00402	CbGpPWpGaD
Celecoxib—Nervousness—Topiramate—migraine	5.8e-05	0.000552	CcSEcCtD
Celecoxib—Anaphylactic shock—Gabapentin—migraine	5.79e-05	0.000552	CcSEcCtD
Celecoxib—Oedema—Gabapentin—migraine	5.79e-05	0.000552	CcSEcCtD
Celecoxib—Back pain—Topiramate—migraine	5.77e-05	0.00055	CcSEcCtD
Celecoxib—Feeling abnormal—Valproic Acid—migraine	5.76e-05	0.000548	CcSEcCtD
Celecoxib—Infection—Gabapentin—migraine	5.75e-05	0.000548	CcSEcCtD
Celecoxib—Muscle spasms—Topiramate—migraine	5.74e-05	0.000547	CcSEcCtD
Celecoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	5.72e-05	0.00396	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Valproic Acid—migraine	5.71e-05	0.000544	CcSEcCtD
Celecoxib—Shock—Gabapentin—migraine	5.7e-05	0.000543	CcSEcCtD
Celecoxib—Nervous system disorder—Gabapentin—migraine	5.68e-05	0.000541	CcSEcCtD
Celecoxib—Thrombocytopenia—Gabapentin—migraine	5.67e-05	0.00054	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Timolol—migraine	5.66e-05	0.00054	CcSEcCtD
Celecoxib—Tachycardia—Gabapentin—migraine	5.65e-05	0.000539	CcSEcCtD
Celecoxib—CA6—Metabolism—CACNA1A—migraine	5.65e-05	0.00391	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CACNA1A—migraine	5.65e-05	0.00391	CbGpPWpGaD
Celecoxib—Vision blurred—Topiramate—migraine	5.62e-05	0.000536	CcSEcCtD
Celecoxib—Skin disorder—Gabapentin—migraine	5.62e-05	0.000536	CcSEcCtD
Celecoxib—Insomnia—Timolol—migraine	5.62e-05	0.000536	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—SCN2A—migraine	5.62e-05	0.00389	CbGpPWpGaD
Celecoxib—Hyperhidrosis—Gabapentin—migraine	5.6e-05	0.000533	CcSEcCtD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TGFBR2—migraine	5.59e-05	0.00387	CbGpPWpGaD
Celecoxib—Paraesthesia—Timolol—migraine	5.58e-05	0.000532	CcSEcCtD
Celecoxib—Urticaria—Valproic Acid—migraine	5.55e-05	0.000529	CcSEcCtD
Celecoxib—Dyspnoea—Timolol—migraine	5.54e-05	0.000528	CcSEcCtD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—FOS—migraine	5.54e-05	0.00383	CbGpPWpGaD
Celecoxib—Somnolence—Timolol—migraine	5.53e-05	0.000527	CcSEcCtD
Celecoxib—Abdominal pain—Valproic Acid—migraine	5.52e-05	0.000526	CcSEcCtD
Celecoxib—Body temperature increased—Valproic Acid—migraine	5.52e-05	0.000526	CcSEcCtD
Celecoxib—Anorexia—Gabapentin—migraine	5.52e-05	0.000526	CcSEcCtD
Celecoxib—Anaemia—Topiramate—migraine	5.52e-05	0.000526	CcSEcCtD
Celecoxib—Dyspepsia—Timolol—migraine	5.47e-05	0.000522	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—HTR1D—migraine	5.46e-05	0.00378	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—HTR3A—migraine	5.45e-05	0.00377	CbGpPWpGaD
Celecoxib—Decreased appetite—Timolol—migraine	5.4e-05	0.000515	CcSEcCtD
Celecoxib—PDPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	5.4e-05	0.00374	CbGpPWpGaD
Celecoxib—Gastrointestinal disorder—Timolol—migraine	5.37e-05	0.000512	CcSEcCtD
Celecoxib—Vertigo—Topiramate—migraine	5.36e-05	0.000511	CcSEcCtD
Celecoxib—Fatigue—Timolol—migraine	5.36e-05	0.000511	CcSEcCtD
Celecoxib—Syncope—Topiramate—migraine	5.35e-05	0.00051	CcSEcCtD
Celecoxib—Leukopenia—Topiramate—migraine	5.34e-05	0.000509	CcSEcCtD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—FOS—migraine	5.32e-05	0.00369	CbGpPWpGaD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TNF—migraine	5.3e-05	0.00367	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Gabapentin—migraine	5.28e-05	0.000503	CcSEcCtD
Celecoxib—Palpitations—Topiramate—migraine	5.27e-05	0.000503	CcSEcCtD
Celecoxib—CA5B—Metabolism—CACNA1A—migraine	5.27e-05	0.00365	CbGpPWpGaD
Celecoxib—Loss of consciousness—Topiramate—migraine	5.25e-05	0.0005	CcSEcCtD
Celecoxib—Insomnia—Gabapentin—migraine	5.24e-05	0.000499	CcSEcCtD
Celecoxib—Cough—Topiramate—migraine	5.21e-05	0.000496	CcSEcCtD
Celecoxib—Paraesthesia—Gabapentin—migraine	5.2e-05	0.000495	CcSEcCtD
Celecoxib—MAPK14—MyD88 cascade initiated on plasma membrane—FOS—migraine	5.17e-05	0.00358	CbGpPWpGaD
Celecoxib—Dyspnoea—Gabapentin—migraine	5.16e-05	0.000492	CcSEcCtD
Celecoxib—Hypertension—Topiramate—migraine	5.15e-05	0.000491	CcSEcCtD
Celecoxib—Somnolence—Gabapentin—migraine	5.15e-05	0.000491	CcSEcCtD
Celecoxib—Hypersensitivity—Valproic Acid—migraine	5.15e-05	0.00049	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—MEF2D—migraine	5.14e-05	0.00356	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	5.12e-05	0.00355	CbGpPWpGaD
Celecoxib—Feeling abnormal—Timolol—migraine	5.12e-05	0.000488	CcSEcCtD
Celecoxib—Dyspepsia—Gabapentin—migraine	5.1e-05	0.000486	CcSEcCtD
Celecoxib—Gastrointestinal pain—Timolol—migraine	5.08e-05	0.000485	CcSEcCtD
Celecoxib—Arthralgia—Topiramate—migraine	5.08e-05	0.000484	CcSEcCtD
Celecoxib—Myalgia—Topiramate—migraine	5.08e-05	0.000484	CcSEcCtD
Celecoxib—Chest pain—Topiramate—migraine	5.08e-05	0.000484	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—HTR2B—migraine	5.08e-05	0.00352	CbGpPWpGaD
Celecoxib—Anxiety—Topiramate—migraine	5.06e-05	0.000483	CcSEcCtD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	5.05e-05	0.0035	CbGpPWpGaD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	5.05e-05	0.000481	CcSEcCtD
Celecoxib—Decreased appetite—Gabapentin—migraine	5.03e-05	0.00048	CcSEcCtD
Celecoxib—MAPK14—MyD88 dependent cascade initiated on endosome—FOS—migraine	5.03e-05	0.00349	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—MTHFR—migraine	5.02e-05	0.00348	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—BDNF—migraine	5.02e-05	0.00348	CbGpPWpGaD
Celecoxib—Asthenia—Valproic Acid—migraine	5.01e-05	0.000478	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Gabapentin—migraine	5e-05	0.000476	CcSEcCtD
Celecoxib—Fatigue—Gabapentin—migraine	4.99e-05	0.000476	CcSEcCtD
Celecoxib—Dry mouth—Topiramate—migraine	4.97e-05	0.000474	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—HTR1D—migraine	4.96e-05	0.00344	CbGpPWpGaD
Celecoxib—Constipation—Gabapentin—migraine	4.95e-05	0.000472	CcSEcCtD
Celecoxib—MAPK14—TCR Signaling Pathway—FOS—migraine	4.94e-05	0.00342	CbGpPWpGaD
Celecoxib—Pruritus—Valproic Acid—migraine	4.94e-05	0.000471	CcSEcCtD
Celecoxib—Urticaria—Timolol—migraine	4.94e-05	0.000471	CcSEcCtD
Celecoxib—Body temperature increased—Timolol—migraine	4.91e-05	0.000468	CcSEcCtD
Celecoxib—Abdominal pain—Timolol—migraine	4.91e-05	0.000468	CcSEcCtD
Celecoxib—Confusional state—Topiramate—migraine	4.91e-05	0.000468	CcSEcCtD
Celecoxib—MAPK14—TWEAK Signaling Pathway—TNF—migraine	4.89e-05	0.00339	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CACNA1A—migraine	4.89e-05	0.00338	CbGpPWpGaD
Celecoxib—Oedema—Topiramate—migraine	4.87e-05	0.000464	CcSEcCtD
Celecoxib—MAPK14—Corticotropin-releasing hormone—FOS—migraine	4.86e-05	0.00336	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	4.86e-05	0.00336	CbGpPWpGaD
Celecoxib—Infection—Topiramate—migraine	4.84e-05	0.000461	CcSEcCtD
Celecoxib—Shock—Topiramate—migraine	4.79e-05	0.000457	CcSEcCtD
Celecoxib—Diarrhoea—Valproic Acid—migraine	4.78e-05	0.000455	CcSEcCtD
Celecoxib—Nervous system disorder—Topiramate—migraine	4.78e-05	0.000455	CcSEcCtD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	4.77e-05	0.00331	CbGpPWpGaD
Celecoxib—Feeling abnormal—Gabapentin—migraine	4.77e-05	0.000455	CcSEcCtD
Celecoxib—Thrombocytopenia—Topiramate—migraine	4.77e-05	0.000455	CcSEcCtD
Celecoxib—Tachycardia—Topiramate—migraine	4.75e-05	0.000453	CcSEcCtD
Celecoxib—Gastrointestinal pain—Gabapentin—migraine	4.73e-05	0.000451	CcSEcCtD
Celecoxib—Skin disorder—Topiramate—migraine	4.73e-05	0.000451	CcSEcCtD
Celecoxib—Hyperhidrosis—Topiramate—migraine	4.71e-05	0.000449	CcSEcCtD
Celecoxib—Anorexia—Topiramate—migraine	4.64e-05	0.000442	CcSEcCtD
Celecoxib—Dizziness—Valproic Acid—migraine	4.62e-05	0.00044	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—HTR2B—migraine	4.61e-05	0.00319	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TGFBR2—migraine	4.61e-05	0.00319	CbGpPWpGaD
Celecoxib—Urticaria—Gabapentin—migraine	4.6e-05	0.000438	CcSEcCtD
Celecoxib—Hypersensitivity—Timolol—migraine	4.58e-05	0.000437	CcSEcCtD
Celecoxib—MAPK14—MyD88-independent cascade—FOS—migraine	4.58e-05	0.00317	CbGpPWpGaD
Celecoxib—Body temperature increased—Gabapentin—migraine	4.58e-05	0.000436	CcSEcCtD
Celecoxib—Abdominal pain—Gabapentin—migraine	4.58e-05	0.000436	CcSEcCtD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—FOS—migraine	4.47e-05	0.0031	CbGpPWpGaD
Celecoxib—Asthenia—Timolol—migraine	4.46e-05	0.000425	CcSEcCtD
Celecoxib—Vomiting—Valproic Acid—migraine	4.44e-05	0.000423	CcSEcCtD
Celecoxib—MAPK14—MAPK Signaling Pathway—BDNF—migraine	4.44e-05	0.00307	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Topiramate—migraine	4.44e-05	0.000423	CcSEcCtD
Celecoxib—Insomnia—Topiramate—migraine	4.41e-05	0.00042	CcSEcCtD
Celecoxib—Rash—Valproic Acid—migraine	4.4e-05	0.00042	CcSEcCtD
Celecoxib—Dermatitis—Valproic Acid—migraine	4.4e-05	0.000419	CcSEcCtD
Celecoxib—Pruritus—Timolol—migraine	4.4e-05	0.000419	CcSEcCtD
Celecoxib—Headache—Valproic Acid—migraine	4.38e-05	0.000417	CcSEcCtD
Celecoxib—Paraesthesia—Topiramate—migraine	4.37e-05	0.000417	CcSEcCtD
Celecoxib—Dyspnoea—Topiramate—migraine	4.34e-05	0.000414	CcSEcCtD
Celecoxib—Somnolence—Topiramate—migraine	4.33e-05	0.000413	CcSEcCtD
Celecoxib—Dyspepsia—Topiramate—migraine	4.29e-05	0.000409	CcSEcCtD
Celecoxib—Hypersensitivity—Gabapentin—migraine	4.27e-05	0.000407	CcSEcCtD
Celecoxib—Diarrhoea—Timolol—migraine	4.25e-05	0.000405	CcSEcCtD
Celecoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	4.25e-05	0.00295	CbGpPWpGaD
Celecoxib—Decreased appetite—Topiramate—migraine	4.23e-05	0.000404	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Topiramate—migraine	4.21e-05	0.000401	CcSEcCtD
Celecoxib—Fatigue—Topiramate—migraine	4.2e-05	0.0004	CcSEcCtD
Celecoxib—Constipation—Topiramate—migraine	4.17e-05	0.000397	CcSEcCtD
Celecoxib—Asthenia—Gabapentin—migraine	4.15e-05	0.000396	CcSEcCtD
Celecoxib—Nausea—Valproic Acid—migraine	4.15e-05	0.000395	CcSEcCtD
Celecoxib—MAPK14—Activated TLR4 signalling—FOS—migraine	4.12e-05	0.00285	CbGpPWpGaD
Celecoxib—Dizziness—Timolol—migraine	4.11e-05	0.000392	CcSEcCtD
Celecoxib—Pruritus—Gabapentin—migraine	4.1e-05	0.00039	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—MTHFR—migraine	4.09e-05	0.00283	CbGpPWpGaD
Celecoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	4.05e-05	0.00281	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RAMP1—migraine	4.03e-05	0.00279	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CALCRL—migraine	4.03e-05	0.00279	CbGpPWpGaD
Celecoxib—Feeling abnormal—Topiramate—migraine	4.01e-05	0.000383	CcSEcCtD
Celecoxib—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	4.01e-05	0.00278	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.01e-05	0.00277	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Topiramate—migraine	3.98e-05	0.00038	CcSEcCtD
Celecoxib—Diarrhoea—Gabapentin—migraine	3.96e-05	0.000378	CcSEcCtD
Celecoxib—Vomiting—Timolol—migraine	3.95e-05	0.000377	CcSEcCtD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—FOS—migraine	3.95e-05	0.00274	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Hypertrophic Response—TNF—migraine	3.94e-05	0.00273	CbGpPWpGaD
Celecoxib—Rash—Timolol—migraine	3.92e-05	0.000374	CcSEcCtD
Celecoxib—Dermatitis—Timolol—migraine	3.92e-05	0.000373	CcSEcCtD
Celecoxib—CA4—Metabolism—CACNA1A—migraine	3.9e-05	0.0027	CbGpPWpGaD
Celecoxib—Headache—Timolol—migraine	3.89e-05	0.000371	CcSEcCtD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	3.87e-05	0.00268	CbGpPWpGaD
Celecoxib—Urticaria—Topiramate—migraine	3.87e-05	0.000369	CcSEcCtD
Celecoxib—Abdominal pain—Topiramate—migraine	3.85e-05	0.000367	CcSEcCtD
Celecoxib—Body temperature increased—Topiramate—migraine	3.85e-05	0.000367	CcSEcCtD
Celecoxib—Dizziness—Gabapentin—migraine	3.83e-05	0.000365	CcSEcCtD
Celecoxib—ALB—Transmembrane transport of small molecules—TRPM8—migraine	3.83e-05	0.00265	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—BDNF—migraine	3.76e-05	0.00261	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CACNA1A—migraine	3.74e-05	0.00259	CbGpPWpGaD
Celecoxib—Nausea—Timolol—migraine	3.69e-05	0.000352	CcSEcCtD
Celecoxib—Vomiting—Gabapentin—migraine	3.68e-05	0.000351	CcSEcCtD
Celecoxib—Rash—Gabapentin—migraine	3.65e-05	0.000348	CcSEcCtD
Celecoxib—Dermatitis—Gabapentin—migraine	3.65e-05	0.000348	CcSEcCtD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—FOS—migraine	3.64e-05	0.00252	CbGpPWpGaD
Celecoxib—Headache—Gabapentin—migraine	3.63e-05	0.000346	CcSEcCtD
Celecoxib—Hypersensitivity—Topiramate—migraine	3.59e-05	0.000342	CcSEcCtD
Celecoxib—Asthenia—Topiramate—migraine	3.49e-05	0.000333	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—FOS—migraine	3.49e-05	0.00242	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—FOS—migraine	3.46e-05	0.0024	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—FOS—migraine	3.45e-05	0.00239	CbGpPWpGaD
Celecoxib—Pruritus—Topiramate—migraine	3.45e-05	0.000328	CcSEcCtD
Celecoxib—Nausea—Gabapentin—migraine	3.44e-05	0.000328	CcSEcCtD
Celecoxib—PDPK1—Disease—LRP1—migraine	3.43e-05	0.00237	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—FOS—migraine	3.39e-05	0.00235	CbGpPWpGaD
Celecoxib—Diarrhoea—Topiramate—migraine	3.33e-05	0.000318	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—HTR1B—migraine	3.31e-05	0.00229	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—MTHFR—migraine	3.25e-05	0.00225	CbGpPWpGaD
Celecoxib—Dizziness—Topiramate—migraine	3.22e-05	0.000307	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—HTR1A—migraine	3.19e-05	0.00221	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CACNA1A—migraine	3.15e-05	0.00218	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—NPS—migraine	3.14e-05	0.00217	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—TAC1—migraine	3.14e-05	0.00217	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—FOS—migraine	3.12e-05	0.00216	CbGpPWpGaD
Celecoxib—Vomiting—Topiramate—migraine	3.1e-05	0.000295	CcSEcCtD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—FOS—migraine	3.09e-05	0.00214	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—HTR2C—migraine	3.08e-05	0.00213	CbGpPWpGaD
Celecoxib—Rash—Topiramate—migraine	3.07e-05	0.000293	CcSEcCtD
Celecoxib—Dermatitis—Topiramate—migraine	3.07e-05	0.000292	CcSEcCtD
Celecoxib—Headache—Topiramate—migraine	3.05e-05	0.000291	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—HTR1B—migraine	3.01e-05	0.00208	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3e-05	0.00208	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—FOS—migraine	3e-05	0.00208	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—EDNRA—migraine	2.99e-05	0.00207	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR1D—migraine	2.93e-05	0.00203	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	2.9e-05	0.00201	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	2.9e-05	0.00201	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	2.9e-05	0.00201	CbGpPWpGaD
Celecoxib—Nausea—Topiramate—migraine	2.89e-05	0.000276	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—HTR1A—migraine	2.89e-05	0.002	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CALCA—migraine	2.88e-05	0.002	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—TAC1—migraine	2.85e-05	0.00197	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—NPS—migraine	2.85e-05	0.00197	CbGpPWpGaD
Celecoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	2.81e-05	0.00194	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HTR2C—migraine	2.79e-05	0.00194	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—FOS—migraine	2.76e-05	0.00192	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR2B—migraine	2.72e-05	0.00189	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EDNRA—migraine	2.72e-05	0.00188	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	2.72e-05	0.00188	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—HTR7—migraine	2.7e-05	0.00187	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CALCA—migraine	2.62e-05	0.00181	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	2.56e-05	0.00177	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—FOS—migraine	2.54e-05	0.00176	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—HTR3A—migraine	2.47e-05	0.00171	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HTR7—migraine	2.45e-05	0.0017	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—migraine	2.4e-05	0.00167	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—LRP1—migraine	2.4e-05	0.00166	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CALCA—migraine	2.21e-05	0.00153	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—TNF—migraine	2.16e-05	0.0015	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—FOS—migraine	2.15e-05	0.00149	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RAMP1—migraine	2.1e-05	0.00145	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALCRL—migraine	2.1e-05	0.00145	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—FOS—migraine	2.09e-05	0.00145	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.92e-05	0.00133	CbGpPWpGaD
Celecoxib—CA14—Metabolism—MTHFR—migraine	1.92e-05	0.00133	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—HTR2A—migraine	1.89e-05	0.00131	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—migraine	1.88e-05	0.0013	CbGpPWpGaD
Celecoxib—CA6—Metabolism—MTHFR—migraine	1.87e-05	0.00129	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—MTHFR—migraine	1.87e-05	0.00129	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOTCH4—migraine	1.84e-05	0.00127	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFBR2—migraine	1.78e-05	0.00123	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR1B—migraine	1.78e-05	0.00123	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TNF—migraine	1.76e-05	0.00122	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—MTHFR—migraine	1.74e-05	0.00121	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—migraine	1.73e-05	0.0012	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HTR2A—migraine	1.71e-05	0.00119	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR1A—migraine	1.71e-05	0.00118	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PGR—migraine	1.68e-05	0.00117	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NPS—migraine	1.68e-05	0.00117	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TAC1—migraine	1.68e-05	0.00117	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR2C—migraine	1.65e-05	0.00114	CbGpPWpGaD
Celecoxib—CA12—Metabolism—MTHFR—migraine	1.62e-05	0.00112	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—migraine	1.61e-05	0.00112	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EDNRA—migraine	1.61e-05	0.00111	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOTCH3—migraine	1.56e-05	0.00108	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CALCA—migraine	1.55e-05	0.00107	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR1D—migraine	1.52e-05	0.00105	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NOTCH4—migraine	1.47e-05	0.00102	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.46e-05	0.00101	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR7—migraine	1.45e-05	0.001	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MTHFR—migraine	1.44e-05	0.001	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2B—migraine	1.42e-05	0.000981	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—migraine	1.4e-05	0.000968	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—migraine	1.37e-05	0.000947	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PGR—migraine	1.35e-05	0.000932	CbGpPWpGaD
Celecoxib—CA4—Metabolism—MTHFR—migraine	1.29e-05	0.000893	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—FOS—migraine	1.25e-05	0.000868	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NOTCH3—migraine	1.25e-05	0.000866	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LRP1—migraine	1.25e-05	0.000863	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFBR2—migraine	1.25e-05	0.000862	CbGpPWpGaD
Celecoxib—CA2—Metabolism—MTHFR—migraine	1.24e-05	0.000856	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CACNA1A—migraine	1.21e-05	0.000841	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LRP1—migraine	1.14e-05	0.000788	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—FOS—migraine	1.12e-05	0.000774	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MTHFR—migraine	1.04e-05	0.000721	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR2A—migraine	1.01e-05	0.000701	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CACNA1A—migraine	9.82e-06	0.00068	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOTCH4—migraine	9.56e-06	0.000662	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	9.3e-06	0.000644	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR1B—migraine	9.23e-06	0.000639	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ESR1—migraine	8.99e-06	0.000623	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR1A—migraine	8.88e-06	0.000615	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TAC1—migraine	8.75e-06	0.000606	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NPS—migraine	8.75e-06	0.000606	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PGR—migraine	8.75e-06	0.000606	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2C—migraine	8.58e-06	0.000594	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EDNRA—migraine	8.34e-06	0.000578	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOTCH3—migraine	8.13e-06	0.000563	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CACNA1A—migraine	8.11e-06	0.000562	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CACNA1A—migraine	8.04e-06	0.000557	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALCA—migraine	8.03e-06	0.000556	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR7—migraine	7.51e-06	0.00052	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALCA—migraine	7.33e-06	0.000508	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—ESR1—migraine	7.18e-06	0.000498	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—migraine	6.8e-06	0.000471	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—FOS—migraine	6.51e-06	0.000451	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFBR2—migraine	6.47e-06	0.000448	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFBR2—migraine	5.9e-06	0.000409	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNA1A—migraine	5.3e-06	0.000367	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—migraine	5.26e-06	0.000364	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—migraine	4.79e-06	0.000332	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ESR1—migraine	4.67e-06	0.000324	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—migraine	4.01e-06	0.000278	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—migraine	3.25e-06	0.000225	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—migraine	2.68e-06	0.000186	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—migraine	2.66e-06	0.000184	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—migraine	1.75e-06	0.000121	CbGpPWpGaD
